8-K - 60 Degrees Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Delisting

Regulation Fd

Disclosure

Mandatory

Variant

8-K

Items Reported

3.01

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On January 20, 2026, 60 Degrees Pharmaceuticals, Inc. (the “

Delisting

$1.00$20.0K

7.01

. Regulation FD Disclosure In accordance with Nasdaq Listing Rule 5810(b), the Company is issuing this Current Report on Form 8-K to publicly disclose receipt o

Regulation Fd

Exhibits (1)

8-K

CURRENT REPORT